News Feed

Citius Pharmaceuticals Acquires Dr. Reddy’s Laboratories’ License for Late-Phase 3 Oncology Immunotherapy (E7777) for the Treatment of Cutaneous T-Cell Lymphoma and other Cancer Indications

Citius expands late-stage pipeline with the acquisition of Dr. Reddy’s exclusive license rights to E7777, an improved formulation of previously FDA-approved ONTAK®; the exclusive license is with Eisai Co. Ltd.Patient enrollment has been completed in […]

News Feed

Pennexx Builds a Powerhouse of Advisory Board Members Bringing over 100 Years of Executive Marketing and Business Experience to the Company and its Shareholders to Continue the Implementation of YourSocialOffers.com (YSO).

PHILADELPHIA, PA / ACCESSWIRE / August 17, 2021 / Pennexx’s (OTCMKTS:PNNX) powerhouse advisory board discussed continued implementation and growth plans for https://YourSocialOffers.com (YSO). Pennexx hosted this valuable workshop with our newly formed Advisory Board Members: Mr. Tom Coba […]